Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Stemline Therapeutics Inc (NASDAQ:STML)

10.58
Delayed Data
As of Sep 23
 +0.35 / +3.42%
Today’s Change
3.88
Today|||52-Week Range
11.08
+67.67%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Bergstein Ivan
Chief Executive Officer
Sale11/30/201512,235$8.20$100.3K+28.40%
Bergstein Ivan
Chief Executive Officer
Sale3/08/20165,537$5.34$29.6K+101.14%
Gionco David G
Chief Accounting Officer
Sale1/19/20163,171$4.82$15.3K+119.96%
Bergstein Ivan
Chief Executive Officer
Sale2/17/20163,244$4.46$14.5K+143.22%
Hoberman Kenneth
Chief Operating Officer
Sale3/08/20162,412$5.34$12.9K+101.14%
Hoberman Kenneth
Chief Operating Officer
Sale2/17/20161,503$4.54$6.8K+143.22%
Gionco David G
Chief Accounting Officer
Sale3/08/20161,148$5.32$6.1K+101.14%
Gionco David G
Chief Accounting Officer
Sale1/20/201646$4.69$215.74+110.34%
Hoberman Kenneth
Chief Operating Officer
Gift12/31/201560,000$0.00$0.00+67.67%
Bergstein Ivan
Chief Executive Officer
Gift12/31/2015250,000$0.00$0.00+67.67%
Page of 2